The increased risk is mediated through sex-specific genetic alterations in downstream molecules of leptin signaling, which impairs hypothalamic leptin signaling prior to the development of metabolic diseases, and results in the onset of metabolic diseases [37]. The gene discussed is LEP; the disease is metabolic disease.